rs267607084
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_025137.4(SPG11):c.118C>T(p.Gln40*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000691 in 1,446,226 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_025137.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 11Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Illumina, G2P
- amyotrophic lateral sclerosis type 5Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Charcot-Marie-Tooth disease axonal type 2XInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
- juvenile amyotrophic lateral sclerosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SPG11 | NM_025137.4 | c.118C>T | p.Gln40* | stop_gained | Exon 1 of 40 | ENST00000261866.12 | NP_079413.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SPG11 | ENST00000261866.12 | c.118C>T | p.Gln40* | stop_gained | Exon 1 of 40 | 1 | NM_025137.4 | ENSP00000261866.7 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000475 AC: 1AN: 210306 AF XY: 0.00000860 show subpopulations
GnomAD4 exome AF: 6.91e-7 AC: 1AN: 1446226Hom.: 0 Cov.: 32 AF XY: 0.00000139 AC XY: 1AN XY: 718334 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 11 Pathogenic:2Other:1
This sequence change creates a premature translational stop signal (p.Gln40*) in the SPG11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPG11 are known to be pathogenic (PMID: 19105190, 20110243, 22154821, 26556829). This variant is present in population databases (rs267607084, gnomAD 0.004%). This premature translational stop signal has been observed in individuals with hereditary spastic paraplegia and/or juvenile amyotrophic lateral sclerosis (PMID: 17322883, 20110243). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 1111). For these reasons, this variant has been classified as Pathogenic. -
- -
- -
not provided Pathogenic:1
Published functional studies demonstrate a damaging effect and suggest that this variant results in impaired cholesterol distribution in lysosomes and the cell membrane and increases axonal swelling (PMID: 37709208); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 19105190, 20301389, 22154821, 26556829, 20110243, 22696581, 18079167, 29946510, 35026838, 37709208, 17322883) -
Amyotrophic lateral sclerosis type 5 Pathogenic:1
- -
Charcot-Marie-Tooth disease axonal type 2X Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at